NOA HYDRATION facial gel: see if it can improve skin smoothness
Official title: A Prospective, Multicenter, Evaluator-Blinded, Randomized, No-treatment-controlled Study to Evaluate the Safety and Effectiveness of NOA HYDRATION in the Improvement of Skin Quality Including Attributes Such as Skin Smoothness
Run by AbbVie · NCT07880756 · Data updated 2026-11-12
This study tests whether NOA HYDRATION injectable gel can improve facial skin quality and smoothness in Chinese adults.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | AbbVie Industry-sponsored |
| Locations | 4 sites (Beijing, Beijing Municipality and 3 other locations) |
| Status | Recruiting |
| Started | September 16, 2026 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07880756 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults seeking improvement in facial skin quality with moderate-to-severe cheek laxity who meet the FACE-Q and ACSS criteria and have no conflicting medical conditions.
✕Probably not a fit
Some participants may not experience noticeable skin improvement or could experience no change in skin quality.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 trial compares NOA HYDRATION injections to a no-treatment control to see if the gel improves facial skin smoothness in adults. Participants are randomized with a 2:1 ratio favoring the treatment group and receive intradermal injections to the face (excluding the forehead). Approximately 150 adults across seven sites in China will be enrolled and followed to assess safety and effectiveness. Inclusion focuses on adults seeking better skin quality with moderate to severe cheek laxity and dissatisfaction with appearance, while several medical exclusions ensure safety. The study aims to provide evidence on whether this investigational device can meaningfully improve facial skin attributes related to aging.
Why it matters
Potential benefit: If successful, participants may experience improved facial skin smoothness and overall appearance.
How similar studies have gone: Previous studies of similar injectable devices in dermatology have shown potential skin quality benefits but results vary by product and patient factors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Seeking improvement of skin quality including attributes such as skin smoothness * Has a symmetric ACSS score of Moderate (2) or Severe (3) on both cheeks * FACE-Q Satisfaction with Skin Questionnaire sum of raw scores \<= 39 and scores of "Very Dissatisfied" or "Somewhat Dissatisfied" on the following questions: * How hydrated your facial skin looks? * How radiant your facial skin looks? Exclusion Criteria: * History of anaphylaxis or allergy to lidocaine, HA products, or bacterial proteins * Active cutaneous inflammatory or infectious processes on the treatment area * Active autoimmune disease or uncontrolled systemic disease * Temporary soft tissue filler injections in the treatment area within 12 months * Semi-permanent fillers anywhere in the treatment area within 36 months
Where it's running
-
Beijing Hospital /ID# 281119
Beijing, Beijing Municipality, China Recruiting -
Peking Union Medical College Hospital (West) - Xidan Campus /ID# 280945
Beijing, Beijing Municipality, China Recruiting -
Nanjing Drum Tower Hospital /ID# 281047
Nanjing, Jiangsu, China Recruiting -
Zhejiang Provincial People's Hospital /ID# 281041
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Abbvie Call Center
- Email: abbvieclinicaltrials@abbvie.com
- Phone: 844-663-3742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phage-based approach to support gut and skin health
Two bacteriophage treatments are tested over 4 weeks to see if they improve gut and skin health in adults with mild to moderate GI symptoms.
-
RRS HA Long Lasting for Wrinkle Reduction on Photoaged Facial Skin
Aging adults with facial wrinkles from sun exposure will try a hyaluronic acid product to see if it reduces wrinkles and improves skin quality.
-
Fractional CO2 laser plus topical hyaluronic acid, vitamin C and sodium DNA to improve facial skin in people over 30
This will test whether applying hyaluronic acid, vitamin C, and sodium DNA after a fractional CO2 laser session improves facial skin quality in people over 30 with photoaged skin.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.